Shandong Wit Dyne Health Co Ltd Class A 000915
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CN¥19.63
- Day Range
- CN¥19.46–19.68
- 52-Week Range
- CN¥18.41–36.16
- Bid/Ask
- CN¥19.60 / CN¥19.61
- Shares Outstanding
- 234.33M
- Market Cap
- CN¥4.60B
- Volume/Avg
- 3M / 3M
Key Statistics
- Price/Earnings (Normalized)
- 16.68
- Price/Sales
- 3.06
- Dividend Yield (Trailing)
- 12.74%
- Dividend Yield (Forward)
- 12.74%
- Dividend Payment Schedule
- Jul
- Total Yield
- 12.74%
Company Profile
Shandong Wit Dyne Health Co Ltd is engaged in the pharmaceutical industry. The product portfolio includes Azithromycin Granules, Rosiglitazone Tartrate Tablets, Lanso (roxithromycin), Yi Kexin-over 1 year old among others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,719
- Website
- http://www.sd-wit.com
Valuation
Metric | 000915 |
|---|---|
Price/Earnings (Normalized) | 16.68 |
Price/Book Value | 1.80 |
Price/Sales | 3.06 |
Price/Cash Flow | — |
Price/Earnings
000915
Financial Strength
Metric | 000915 |
|---|---|
Quick Ratio | 11.81 |
Current Ratio | 13.03 |
Interest Coverage | — |
Quick Ratio
000915
Profitability
Metric | 000915 |
|---|---|
Return on Assets (Normalized) | 5.54% |
Return on Equity (Normalized) | 9.12% |
Return on Invested Capital (Normalized) | 5.37% |
Return on Assets
000915
Drug Manufacturers - Specialty & Generic Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Merck KGaA ADR MKKGY | LOCK|l^m>!#C | LOCK|H&&%? | $74B | |||
| Teva Pharmaceutical Industries Ltd TEVA | LOCK|yn&&MX?& | LOCK|!np&& | $50B | |||
| Haleon PLC ADR HLN | LOCK|ktcRyB& | LOCK|ST | $40B | |||
| Zoetis Inc Class A ZTS | LOCK|mNZ@Hw@K | LOCK|@h! | $34B | |||
| Viatris Inc VTRS | LOCK|!>#!Y<m | LOCK|q% | $24B | |||
| Elanco Animal Health Inc ELAN | LOCK|NQ | LOCK|BS | $13B | |||
| Dr Reddy's Laboratories Ltd ADR RDY | LOCK|Y<n@MdQ | LOCK|Shg | $12B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A HIMS | LOCK|F!^kN<> | LOCK|<?@ | $5B | |||
| Perrigo Co PLC PRGO | LOCK|@v<j%%w | LOCK|Kh | $2B | |||
| Prestige Consumer Healthcare Inc PBH | LOCK|SPRJk^q | LOCK|Y^!d# | $2B |
United States